Cargando…

Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes

Biologic treatment of type 1 diabetes (T1D) with agents including anti-CD3 (otelixizumab and teplizumab), anti-CD20 (rituximab), LFA3Ig (alafacept), and CTLA4Ig (abatacept) results in transient stabilization of insulin C-peptide, a surrogate for endogenous insulin secretion. With the goal of inducin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linsley, Peter S., Greenbaum, Carla J., Rosasco, Mario, Presnell, Scott, Herold, Kevan C., Dufort, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477779/ https://www.ncbi.nlm.nih.gov/pubmed/29925930 http://dx.doi.org/10.1038/s41435-018-0032-1

Ejemplares similares

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Rituximab Selectively Suppresses Specific Islet Antibodies
por: Yu, Liping, et al.
Publicado: (2011)

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
por: Schmidt, H, et al.
Publicado: (2005)

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
por: Fink, A M, et al.
Publicado: (2013)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Exhausted-like CD8(+) T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects
por: Diggins, Kirsten E., et al.
Publicado: (2021)

Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
por: Barbosa, Mariana, et al.
Publicado: (2023)

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
por: Herold, Kevan C., et al.
Publicado: (2013)

An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma
por: Wang, Liang, et al.
Publicado: (2015)

Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients
por: Nanmoku, Koji, et al.
Publicado: (2019)

Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
por: Lehman, Thomas JA, et al.
Publicado: (2014)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Rituximab therapy for juvenile-onset systemic lupus erythematosus
por: Nwobi, Obioma, et al.
Publicado: (2007)

Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza
por: Lu, Justin Y., et al.
Publicado: (2023)

Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma
por: Hara, Tasuku, et al.
Publicado: (2020)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
por: Reddy, Venkat R, et al.
Publicado: (2021)

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
por: Rosengren, Sanna, et al.
Publicado: (2008)

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
por: Anderson, Randy L., et al.
Publicado: (2022)

Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation
por: Kaes, Janne, et al.
Publicado: (2020)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita, Masatoshi, et al.
Publicado: (2018)

Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab
por: Sansevere, Arnold J., et al.
Publicado: (2020)

Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab
por: Ramachandran, Raja, et al.
Publicado: (2013)

Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Delayed-onset flaccid paralysis related to west Nile virus reactivation following treatment with rituximab: a case report
por: Honig, Asaf, et al.
Publicado: (2014)

Poorly controlled ambulatory blood pressure in outpatients with peripheral arterial disease
por: Dahle, Nina, et al.
Publicado: (2021)

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
por: Bonnet, Isabelle, et al.
Publicado: (2021)

Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines
por: Edvardsen, Kine, et al.
Publicado: (2015)

Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study
por: Zhao, Tian X, et al.
Publicado: (2021)

Elevated UMOD methylation level in peripheral blood is associated with gout risk
por: Yang, Yong, et al.
Publicado: (2017)

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas
por: Ikematsu, S, et al.
Publicado: (2003)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)
por: Sosenko, Jay M., et al.
Publicado: (2010)

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
por: Sosenko, Jay M., et al.
Publicado: (2013)

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts()()
por: Corso, Simona, et al.
Publicado: (2018)

Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
por: Linsley, Peter S., et al.
Publicado: (2014)

Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
por: Slade, Michael, et al.
Publicado: (2016)

Synergistic effects of elevated homocysteine level and abnormal blood lipids on the onset of stroke
por: Hao, Lu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9gvehmqhgo8ji9o57poi44d2j0